Meloxicam (Page 9 of 9)
PRINCIPAL DISPLAY PANEL — 7.5 mg
NDC 64205-106-30
Meloxicam
Tablets, USP
7.5 mg
PHARMACIST: Dispense the Medication
Guide provided separately to each patient.
Rx only 30 Tablets
Each tablet contains:
Meloxicam, USP 7.5 mg
Dispense in a tight, light-resistant
container as defined in the USP
using a child-resistant closure.
Keep container tightly closed.
Keep this and all medication
out of the reach of children.
Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room
Temperature.]
Protect from moisture.
Usual Dosage: See accompanying
prescribing information.
Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.
Mylan.com
Repackaged By:
ReadyMeds
Dothan, AL 36301
RM1066A4
PRINCIPAL DISPLAY PANEL — 15 mg
NDC 64205-108-30
Meloxicam
Tablets, USP
15 mg
PHARMACIST: Dispense the Medication
Guide provided separately to each patient.
Rx only 30 Tablets
Each tablet contains:
Meloxicam, USP 15 mg
Dispense in a tight, light-resistant
container as defined in the USP
using a child-resistant closure.
Keep container tightly closed.
Keep this and all medication
out of the reach of children.
Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room
Temperature.]
Protect from moisture.
Usual Dosage: See accompanyingprescribing information.
Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.
Mylan.com
Repackaged By:
ReadyMeds
Dothan, AL 36301
RM1089A4
MELOXICAM meloxicam tablet | ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
|
MELOXICAM meloxicam tablet | ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
|
Labeler — ReadyMeds (072115132) |
Establishment | |||
Name | Address | ID/FEI | Operations |
ReadyMeds | 072115132 | repack (64205-106), repack (64205-108) |
Revised: 07/2014 ReadyMeds
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.